Hazard ratio for clinical decline in Clinical Dementia Rating-Sum of Boxes was 0.53 for those treated with gantenerumab the longest

Benefits seen in attainment of language and social or motor developmental milestones

Benefits seen for retrograde ejaculation, urinary incontinence, with overall symptom relief and safety similar to that seen with laser surgery

Articular contact was 7.6 mm higher on femoral trochlea in ACLR, contralateral knees due to 8.9-mm longer patellar tendon

Projected 2023 estimates suggest decline in pedestrian, overall traffic deaths compared with 2022

Findings show benefits for four outcomes after surgery

Medication approved for uUTIs in women and pediatric patients aged 12 years and older

Molecular residual disease precedes DFS events in patients receiving osimertinib, placebo; most events occur after osimertinib discontinuation or completion

Odds of leukemia-related mortality higher in rural counties and urban neighborhoods with lower socioeconomic status

Prevalence and severity of refractive astigmatism and corneal astigmatism increased among schoolchildren